MedPath

To Study the efficacy of Shatapushpa and Krushnajeerak in the treatment of Oligomenorrhea (Artavakshaya, decrease quantity of blood loss in menses) the age group of 16 to 30 years

Not yet recruiting
Conditions
Primary oligomenorrhea. Ayurveda Condition: ARTAVAKSHAYAH,
Registration Number
CTRI/2021/09/036993
Lead Sponsor
PDEAs College Of Ayurveda And Research Centre
Brief Summary

Artava dusti is very important among gynaecological problems. The ratio of menstrual disorder is rising in gynaecological practice which is precursor of infertility and other problems, so it requires more attention. Menstrual disorder affect on mental state of women. Many Menstrual disorder i.e secondary amenorrhoea, oligomenorrhoea, require counselling with appropriate treatment. There is an altered physiology in the H-P-O-U axis. Hence this requires attention that can answer the rising question. In Modern medical science Hormonal Treatment which has a good therapeutic utility is used for menstrual disorders but this is not devoid of side effect. So, in contemporary era it is very important to provide a particular etiopathology and treatment for “Artavakshayaâ€. There are many processes and Methods available in Ayurvedic classics to alleviate Artavakshya. But it is yet, the on going research to find out a method of treatment, which is more near to procurance of permanent cure without side effects. It must be easier for administration and warmly acceptable by all class of patients. The problem ,without leading to any side effects like weight gain,mood swings and 5 loss of libido that usually the hormonal pills have on the body.compound. The role of hormones (estrogen-progesterone or contraceptive pills) as a prolonged therapeutic measure especially on unmarried girls for oligomenorrhoea is itself debatable. So there is a great scope of research to find out management with long lasting effect, to treat the entire feature complex with single regimen and find out the treatment for the underlying pathology from Ayurveda for the management of artavakshaya.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
62
Inclusion Criteria
  • Patient in between the age group of 16-30 2.
  • Patients having bleeding requiring less than 1-2 pads on the first day of menses 4.
  • Mentstrual bleeding taking place only 1, 2 days per Cycle 5.
  • Both married and unmarried women 6.
  • Patients presenting with the pratyatma lakshana of artava 7.
  • After screening for covid 19 in covid screening O.
  • D patients will be selected.
Exclusion Criteria
  • Known cases of the following diseases- 1.
  • Prolactinaemias, 2.
  • Graves disease 3.
  • Endometrial tuberculosis 4.
  • Fibrosed/atropic endometrium 5.
  • Uterine synechae 6.
  • Patient with systemic disorder like DM, HTN, TB, Asthma, Congenital abnormalities.
  • Patient with malnutrition, severe anemia (Hb < 8gm %) 8.
  • Lactating women.
  • OCP using women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the efficacy of Shatapushpa and Krushnajeeraka in the management of Artavakshaya3 months with 3 follow ups on every month end.
Secondary Outcome Measures
NameTimeMethod
To study adverse effects, if any.3 months with 3 follow ups on every month end.

Trial Locations

Locations (1)

Ayurved Rugnalaya and Sterling Multispeciality Hospital Pune

🇮🇳

Pune, MAHARASHTRA, India

Ayurved Rugnalaya and Sterling Multispeciality Hospital Pune
🇮🇳Pune, MAHARASHTRA, India
Dr Nayab Shaikh
Principal investigator
08766970447
shaikhnayabayub01@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.